Serum Human Epidermal Growth Factor 2 is a Novel Biomarker for Recurrence and Metastasis in Triple Negative Breast Cancer

Huafeng Yang, Liang Chen, Linfu Zhou, Chun Liu, Tang Lu-bing, Jing Zhang, Fengfeng Fan, Zhenhua Zhong, Guojun Shi, Zhanwen LiClinical 2017 · DOI

Abstract

Patients with TNBC still have an increased serum HER2 concentration, and serum HER2 may be a valuable, novel biomarker for recurrence and metastasis in TNBC.
BibTeX
@inproceedings{yang2017serum,
  author = {Huafeng Yang and Liang Chen and Linfu Zhou and Chun Liu and Tang Lu-bing and Jing Zhang and Fengfeng Fan and Zhenhua Zhong and Guojun Shi and Zhanwen Li},
  title = {{Serum Human Epidermal Growth Factor 2 is a Novel Biomarker for Recurrence and Metastasis in Triple Negative Breast Cancer}},
  booktitle = {Clinical},
  year = {2017},
  doi = {10.7754/clin.lab.2016.160524},
}

Loading related content...

Figure